Showing 4821-4830 of 8897 results for "".
- Acne Breakthrough: Fat Cells in the Skin May Help Fight Acnehttps://practicaldermatology.com/news/fat-cells-in-the-skin-may-help-fight-acne/2461080/New research suggests that fibroblasts outside of hair follicles play a larger role in acne development. Fibroblasts produce an antimicrobial peptide called cathelicidin in skin. To counter an infection within a hair follicle, the surrounding skin undergoes a process called reactiv
- Third Harmonic Bio Launches with an Eye on Chronic Urticariahttps://practicaldermatology.com/news/third-harmonic-bio-launches-with-an-eye-on-chronic-urticaria/2461078/Third Harmonic Bio is launching with the close of a Series B financing campaign. With total capital to date of $155 million, the company plans to fund development of its lead candidate, THB001, through the next phase of human studies for the initial indication of chronic urticaria. 
- FDA Green-lights Casio’s DZ-D100 Dermocamera and the DZ-S50 Scopehttps://practicaldermatology.com/news/fda-green-lights-casios-dz-d100-dermocamera-and-the-dz-s50-scope/2461076/The U.S. Food and Drug Administration (FDA) has cleared Casio’s
- GW Dermatology, La Roche-Posay Establish GW Skin Cancer Research Acceleration Fundhttps://practicaldermatology.com/news/gw-dermatology-la-roche-posay-establish-gw-skin-cancer-research-acceleration-fund/2461074/The Department of Dermatology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) has partnered with La Roche-Posay to establish the La Roche-Posay Skin Cancer Research Acceleration Fund at GW. The $50,000 gift will be used to support the growth
- ASDS Survey Highlights Teledermatology Boom, Staffing Challenges, and Other Ways COVID-19 Upended Practicehttps://practicaldermatology.com/news/asds-survey-sites-teledermatology-boom-staffing-challenges-and-other-ways-pandemic-upended-practice/2461070/From dramatic upticks in the use of teledermatology to staffing challenges and delays in procedures, the ongoing COVID-19 pandemic continues to affect dermatology practices and patients, according to a
- Leadership Changes Take Place at SkinCeuticalshttps://practicaldermatology.com/news/leadership-changes-at-skinceuticals/2461069/Stephanie Kramer is now SkinCeutical’s Global General Manager, and Amy Sloan is the Head of SkinCeuticals U.S, the company reports Sloan brings 15 years of global and U.S. beauty industry experience - 10 of those years with SkinCeuticals - to the role of Head o
- Study: Nutrafol's Core Products Provide Benefits Across Sexes, Ethnicitieshttps://practicaldermatology.com/news/study-nutrafols-core-products-provide-benefits-across-sexes-ethnicities/2461068/Nutrafol’s core products provide improvement in hair growth, coverage, density, and volume across diverse ethnicities, results of a new study show. The six-month, single blind study was conducted by Dr. Sophia Kogan, Tess Marshall, and Dr. Isabelle Raymond to test the effecti
- National Foundation for Cancer Research Taps NYC Dermatologist for Board Seathttps://practicaldermatology.com/news/national-foundation-for-cancer-research-taps-dermatologist-for-board-seat/2461065/The National Foundation for Cancer Research (NFCR) has announced that New York dermatologist Dr. Karen Burke and two others will be joining the board. NFCR was founded in 1973 to support cancer research and public education relating to the prevention, early diagnosis, better treatments
- Study: Knowledge of Skin Cancer Risk May Limit Tanning Bed Use, Unhealthy Behaviorshttps://practicaldermatology.com/news/study-knowledge-of-skin-cancer-risk-may-limit-tanning-bed-use-unhealthy-behaviors/2461064/When patients know their risk for skin cancer, they may change their behaviors to lower their chances of developing melanoma, a new study suggests. A recent
- Merz Aesthetics Launches Radiesse (+) as First and Only Aesthetic Injectable to Improve Moderate to Severe Loss of Jawline Contourhttps://practicaldermatology.com/news/merz-aesthetics-launches-radiesse-as-first-and-only-aesthetic-injectable-to-improve-moderate-to-severe-loss-of-jawline-contour/2461062/Merz Aesthetics is launching Radiesse (+) Lidocaine for jawline contouring in adults over the age of 21. Radiesse (+) is the first and only U.S. Food and Drug Administration (FDA)-approved injectable treatment for jawline contour improvement. The FDA approved the supplemental